|
Fibrinolysis
Citations 1-10 of 120 total displayed.
|
Most recent content
(29 Oct 2009):
|
- Articles
Ancrod in Acute Ischemic Stroke. Results of 500 Subjects Beginning Treatment Within 6 Hours of Stroke Onset in the Ancrod Stroke Program
- David E. Levy, Gregory J. del Zoppo, Bart M. Demaerschalk, Andrew M. Demchuk, Hans-Christoph Diener, George Howard, Markku Kaste, Arthur M. Pancioli, Carmen Spatareanu, and Warren W. Wasiewski
Stroke published October 29, 2009, doi:10.1161/STROKEAHA.109.565119
[Abstract]
|
Past content
(since Aug 2000):
|
- Original Contributions
Migraine and Biomarkers of Endothelial Activation in Young Women
- Gretchen E. Tietjen, Nabeel A. Herial, Leah White, Christine Utley, Janet M. Kosmyna, and Sadik A. Khuder
Stroke 2009;40:2977-2982; published online before print as doi:10.1161/STROKEAHA.109.547901
[Abstract]
[Full text]
- Original Contributions
Minocycline and Tissue-Type Plasminogen Activator for Stroke: Assessment of Interaction Potential
- Livia S. Machado, Irina Y. Sazonova, Anna Kozak, Daniel C. Wiley, Azza B. El-Remessy, Adviye Ergul, David C. Hess, Jennifer L. Waller, and Susan C. Fagan
Stroke 2009;40:3028-3033; published online before print as doi:10.1161/STROKEAHA.109.556852
[Abstract]
[Full text]
- Articles
Minocycline and Tissue-Type Plasminogen Activator for Stroke. Assessment of Interaction Potential
- Livia S. Machado, Irina Y. Sazonova, Anna Kozak, Daniel C. Wiley, Azza B. El-Remessy, Adviye Ergul, David C. Hess, Jennifer L. Waller, and Susan C. Fagan
Stroke published July 23, 2009, doi:10.1161/STROKEAHA.109.556852
[Abstract]
- Articles
Migraine and Biomarkers of Endothelial Activation in Young Women
- Gretchen E. Tietjen, Nabeel A. Herial, Leah White, Christine Utley, Janet M. Kosmyna, and Sadik A. Khuder
Stroke published July 16, 2009, doi:10.1161/STROKEAHA.109.547901
[Abstract]
- Original Contributions
Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3- to 4.5-Hour Window: Joint Outcome Table Analysis of the ECASS 3 Trial
- Jeffrey L. Saver, Jeffrey Gornbein, James Grotta, David Liebeskind, Helmi Lutsep, Lee Schwamm, Phillip Scott, and Sidney Starkman
Stroke 2009;40:2433-2437; published online before print as doi:10.1161/STROKEAHA.108.543561
[Abstract]
[Full text]
- Articles
Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3- to 4.5-Hour Window. Joint Outcome Table Analysis of the ECASS 3 Trial
- Jeffrey L. Saver, Jeffrey Gornbein, James Grotta, David Liebeskind, Helmi Lutsep, Lee Schwamm, Phillip Scott, and Sidney Starkman
Stroke published June 4, 2009, doi:10.1161/STROKEAHA.108.543561
[Abstract]
- Original Contributions
Prior Statin Use, Intracranial Hemorrhage, and Outcome After Intra-Arterial Thrombolysis for Acute Ischemic Stroke
- Niklaus Meier, Krassen Nedeltchev, Caspar Brekenfeld, Aekaterini Galimanis, Urs Fischer, Oliver Findling, Luca Remonda, Gerhard Schroth, Heinrich P. Mattle, and Marcel Arnold
Stroke 2009;40:1729-1737; published online before print as doi:10.1161/STROKEAHA.108.532473
[Abstract]
[Full text]
- Original Contributions
Expediting MRI-Based Proof-of-Concept Stroke Trials Using an Earlier Imaging End Point
- Martin Ebinger, Soren Christensen, Deidre A. De Silva, Mark W. Parsons, Christopher R. Levi, Kenneth S. Butcher, Christopher F. Bladin, P. Alan Barber, Geoffrey A. Donnan, Stephen M. Davis for the EPITHET Investigators
Stroke 2009;40:1353-1358; published online before print as doi:10.1161/STROKEAHA.108.532622
[Abstract]
[Full text]
- Research Letters
Altered Fibrin Clot Structure/Function in Patients With Cryptogenic Ischemic Stroke
- Anetta Undas, Piotr Podolec, Krystyna Zawilska, Monika Pieculewicz, Ireneusz Jedlinski, Ewa Stepien, Ewa Konarska-Kuszewska, Przemyslaw Weglarz, Malgorzata Duszynska, Ewelina Hanschke, Tadeusz Przewlocki, and Wieslawa Tracz
Stroke 2009;40:1499-1501; published online before print as doi:10.1161/STROKEAHA.108.532812
[Abstract]
[Full text]
|
|
